No Time to Die: How Kidney Cancer Evades Cell Death
The understanding of the pathogenesis of renal cell carcinoma led to the development of targeted therapies, which dramatically changed the overall survival rate. Nonetheless, despite innovative lines of therapy accessible to patients, the prognosis remains severe in most cases. Kidney cancer rarely...
Main Authors: | Carlo Ganini, Manuela Montanaro, Manuel Scimeca, Giampiero Palmieri, Lucia Anemona, Livia Concetti, Gerry Melino, Pierluigi Bove, Ivano Amelio, Eleonora Candi, Alessandro Mauriello |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/11/6198 |
Similar Items
-
Programmed Cell Death Pathways in Cholangiocarcinoma: Opportunities for Targeted Therapy
by: Manuel Scimeca, et al.
Published: (2023-07-01) -
The Role of Programmed Necrosis in Colorectal Cancer
by: Yu-Qiang Yu, et al.
Published: (2022-09-01) -
Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
by: Rong Tang, et al.
Published: (2020-08-01) -
Regulation of Inflammatory Cell Death by Phosphorylation
by: Wen Xu, et al.
Published: (2022-03-01) -
Dying to Defend: Neutrophil Death Pathways and their Implications in Immunity
by: Haiyue Tu, et al.
Published: (2024-02-01)